- Editor's PickSeana Smith•6 hours agoPotential Twitter bid; Goldman Sachs upgrades Eli Lilly; US Labor Dept launches review of Wells Fargo
Yahoo Finance is tracking the stocks you’re following, based on your Yahoo Finance ticker searches.
- Financial Times•43 minutes ago
Eli Lilly shares will rally by almost a fifth over the next year given the pharmaceutical group's slim reliance on drug price increases and a strong roster of treatments in its pipeline, Goldman Sachs ...
- Investor's Business Daily•59 minutes ago
Lilly's Alzheimer's drug could add $7.5 billion in peak sales and "super charge" earnings, says Goldman Sachs.
Eli Lilly and Company (LLY)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||80.71 x 100|
|Ask||81.50 x 100|
|Day's Range||79.61 - 80.93|
|52wk Range||67.88 - 88.48|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||34.86|
|Avg Vol (3m)||3,603,545|
|Dividend & Yield||2.04 (2.51%)|